No connection

Search Results

Analysis Neutral

Telix Pharmaceuticals Q1 Group Revenue Rises; Stock Up

Apr 07, 2026 02:35 UTC

(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) reported that its group revenue for the first quarter of fiscal year 2016 increased about 24% to US$230 million, from US$186 million last year..

  • April 06, 2026 — 10:35 pm EDT Written byRTTNews
  • comforRTTNews-> (RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX
  • AX) reported that its group revenue for the first quarter of fiscal year 2016 increased about 24% to US$230 million, from US$186 million last year

April 06, 2026 — 10:35 pm EDT Written byRTTNews.comforRTTNews-> (RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) reported that its group revenue for the first quarter of fiscal year 2016 increased about 24% to US$230 million, from US$186 million last year. Precision Medicine revenue for the quarter were US$186 million, up 23% from prior year. The company reaffirmed its revenue guidance for fiscal year 2026 in a range of US$950 million to US$970 million. TLX.AX was trading at A$13.54 up A$0.59 or 4.56%. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile